Techniques for Assessing Cellular Energy Metabolism: Core Mechanisms of Glycolysis and the TCA Cycle, with Practical Assay-Kit Workflows
Techniques for Assessing Cellular Energy Metabolism: Core Mechanisms of Glycolysis and the TCA Cycle, with Practical Assay-Kit Workflows
Cellular energy metabolism is centered on ATP production and the turnover of reducing equivalents, and is tightly regulated through the uptake, allocation, and oxidation of substrates such as glucose, fatty acids, and amino acids. Glycolysis, pyruvate branching, the mitochondrial tricarboxylic acid (TCA) cycle, and oxidative phosphorylation collectively constitute the principal axis of energy conversion, while also supplying carbon skeletons for nucleotide, lipid, and amino-acid biosynthesis. Across cell types, differentiation states, and stress conditions, this metabolic network undergoes characteristic reprogramming, producing measurable differences in indicators such as glucose uptake and consumption, lactate and pyruvate production, citrate and dihydroxyacetone phosphate (DHAP) levels, and ATP content. By integrating these metabolic readouts with assays of key enzyme activities, cellular energy metabolism can be dissected along the full chain of “substrate input–carbon-flow allocation–TCA cycling–energy output,” thereby providing biochemical evidence for mechanism studies and pharmacodynamic evaluation.
I. Overall background of cellular energy metabolism
1.1 The role of cellular energy metabolism in life processes
(1) Core functions of ATP and reducing equivalents
Most energy-requiring intracellular processes—including maintenance of transmembrane ion gradients, muscle contraction, vesicular trafficking, protein and nucleic-acid synthesis, and diverse signal-transduction events—depend directly or indirectly on ATP levels and on the supply of reducing equivalents such as NADH, FADH₂, and NADPH. By regulating the generation and consumption of these high-energy molecules and reducing equivalents, the metabolic network maintains intracellular homeostasis and sustains continuous cellular function.
1.2 Major energy substrates and their interrelationships
(1) The central role of glucose metabolism
Glucose is degraded in the cytosol through glycolysis to pyruvate, accompanied by the generation of small amounts of ATP and NADH. A portion of pyruvate is reduced to lactate via lactate dehydrogenase (LDH) to regenerate NAD⁺, while another portion enters mitochondria and is converted to acetyl-CoA to fuel the TCA cycle. Glycolytic intermediates can also enter the pentose phosphate pathway, generating ribose-5-phosphate for nucleotide synthesis and NADPH for antioxidant defense and lipid biosynthesis. Thus, glucose serves both as an energy source and as a carbon donor feeding multiple anabolic pathways.
(2) Fatty-acid oxidation and basal metabolic load
Fatty acids undergo β-oxidation to generate large amounts of acetyl-CoA and NADH/FADH₂, providing a high-efficiency energy source for many quiescent or long-lived cells under aerobic conditions. Compared with glucose, fatty-acid oxidation typically yields a higher total ATP output per molecule (or per unit mass), but is more dependent on mitochondrial function and oxygen availability. In certain cell types (e.g., cardiomyocytes and subsets of memory T cells), fatty-acid oxidation is an important route for sustaining basal metabolic demand.
(3) Glutamine metabolism and anaplerosis of the TCA cycle
Glutamine is converted to glutamate via glutaminase and transaminases, and is further deaminated to α-ketoglutarate, which enters the TCA cycle to replenish intermediates (anaplerosis). Glutamine also serves as a nitrogen donor for nucleotide synthesis and for the biosynthesis of certain amino acids, and is therefore critical in many highly proliferative cells and immune cells. Glucose and glutamine jointly maintain carbon flux through the TCA cycle and support balance in nitrogen metabolism.
1.3 Metabolic reprogramming and the Warburg effect
(1) Concept and characteristics of the Warburg effect
The Warburg effect describes the phenomenon in which tumor cells maintain high glycolytic activity and produce large amounts of lactate even in the presence of sufficient oxygen (aerobic glycolysis). This state is typically associated with upregulation of glucose transporters and key glycolytic enzymes (e.g., HK, PFK, and PK), along with enhanced lactate production and export. Meanwhile, the TCA cycle is not completely shut down; instead, it is maintained through multiple carbon sources, including glucose and glutamine, to supply reducing equivalents and intermediates. Fundamentally, this reprogramming represents a rebalancing between energy metabolism and biosynthetic metabolism in the context of rapid proliferation.
(2) Metabolic rearrangements in non-tumor cells
Non-tumor cells also undergo metabolic reprogramming during immune activation, stem-cell differentiation, and hypoxic adaptation. For example, effector T cells preferentially adopt high glycolytic flux to respond rapidly to antigen stimulation, whereas memory T cells rely more on fatty-acid oxidation and the TCA cycle. Metabolic pathways are therefore recognized as a key layer regulating cell fate and effector functions, making metabolic profiling biologically informative in these settings.
II. Early glycolysis: from glucose uptake to pyruvate formation
2.1 Transmembrane transport and cellular uptake of glucose
(1) Glucose transport and its regulation
Glucose enters cells via GLUT-family transporters. Different cell types express distinct isoforms with different affinities and transport capacities. Growth-factor signaling, hypoxia signaling, and nutrient status can modulate glucose uptake by altering GLUT expression and membrane localization. Once phosphorylated by hexokinase to glucose-6-phosphate (G6P), glucose is generally retained intracellularly and cannot readily be exported; however, in cells/tissues expressing glucose-6-phosphatase (e.g., liver and kidney), G6P can be dephosphorylated back to glucose for export.
(2) Principles of glucose uptake assays
Glucose uptake is commonly assessed using fluorescent substrates or glucose analog tracers over a defined time window to quantify cellular uptake. Such assays reflect the combined effects of transmembrane transport and initial phosphorylation, enabling comparisons of substrate input capacity across treatments or cell types. When combined with measurements of glucose depletion in culture media, these assays can help distinguish “altered uptake capacity” from “altered downstream metabolic flux.”
(3) Related products (Aladdin)
Analyte/Readout | Catalog No. | Product Name | Grade and Purity | Application |
Glucose content (medium/supernatant/cell lysate) | Glucose Colorimetric Detection Kit (GOD-POD Microplate Method) | BioReagent | Quantifies glucose concentration to assess glucose uptake and consumption; suitable for comparing treatment groups or time courses to reflect changes at the substrate-input level | |
Glucose content (medium/supernatant/tissue homogenate, etc.) | Glucose (Glu) Content Assay Kit (GOD-POD, Colorimetric Method) | BioReagent | Colorimetric quantification of glucose for routine spectrophotometric readout; can be combined with lactate/pyruvate measurements to support interpretation of enhanced glycolysis or limited substrate supply |
2.2 Glycolytic cascade and key rate-limiting steps
(1) Overall features of glycolysis
Glycolysis comprises ten enzyme-catalyzed steps that convert one molecule of glucose into two molecules of pyruvate, yielding a net gain of two ATP and two NADH. It occurs in the cytosol and does not require mitochondrial structures; it can proceed under both aerobic and anaerobic conditions. Beyond rapid ATP production, glycolysis supplies multiple intermediates that feed into nucleotide, amino-acid, and lipid precursor synthesis, making it a central hub within high-flux metabolic networks.
(2) Flux control by HK, PFK, and PK
Hexokinase (HK), phosphofructokinase (PFK), and pyruvate kinase (PK) are three major regulatory enzymes positioned at key control points in glycolysis. PFK is widely regarded as the primary rate-limiting step and is regulated by ATP/AMP ratios, citrate, and fructose-2,6-bisphosphate, among other factors. HK sets the initial rate at which glucose is committed to metabolism, while PK governs the terminal formation of pyruvate and—through isoform expression (e.g., PKM1 versus PKM2)—can shape the balance between energy production and biosynthetic/proliferative programs.
(3) Related products (Aladdin)
Analyte/Readout | Catalog No. | Product Name | Grade and Purity | Application |
Hexokinase (HK) activity (glycolytic gatekeeping) | Hexokinase (HK) Activity Assay Kit (WST-8, Micro Method) | BioReagent | Quantifies HK activity in cells/tissues to assess glucose entry via initial phosphorylation; suitable for microplate, low-volume, and parallel multi-sample comparisons; can be paired with glucose measurements to differentiate transport changes from phosphorylation bottlenecks | |
Hexokinase (HK) activity (glycolytic gatekeeping) | Hexokinase (HK) Activity Assay Kit (UV Micro Method) | BioReagent | UV-based micro assay for limited samples; can be integrated with glucose, PFK/PK activity, and pyruvate readouts to localize constraints at the glycolytic input stage | |
Hexokinase (HK) activity (glycolytic gatekeeping) | Hexokinase (HK) Activity Assay Kit (UV Colorimetric Method) | BioReagent | UV-based standard-volume assay for routine workflows; supports between-group comparisons and joint interpretation with glucose/pyruvate/ATP metrics to evaluate glycolytic initiation efficiency | |
Phosphofructokinase (PFK) activity (rate-limiting step) | Phosphofructokinase (PFK) Activity Assay Kit (UV Micro Method) | BioReagent | Quantifies PFK activity to evaluate regulation at the canonical glycolytic bottleneck; suitable for UV micro assays; can be coupled with lactate/pyruvate and ATP to interpret increased or suppressed glycolytic throughput | |
Pyruvate kinase (PK) activity (terminal control point) | Pyruvate Kinase (PK) Activity Assay Kit (UV Micro Method) | BioReagent | Quantifies PK activity to assess terminal glycolytic flux and pyruvate-forming capacity; recommended to interpret together with pyruvate, lactate, and ATP to infer branching directionality | |
Pyruvate kinase (PK) activity (terminal control point) | Pyruvate Kinase (PK) Activity Assay Kit (UV Colorimetric Method) | BioReagent | UV standard-volume assay for PK activity; can be combined with pyruvate, TCA-entry metrics, and ATP to support interpretation of pyruvate allocation toward lactate fermentation versus mitochondrial oxidation |
2.3 Glycolytic intermediates and shunt pathways
(1) Connections to the pentose phosphate pathway and other routes
Glucose-6-phosphate can enter the pentose phosphate pathway to produce NADPH and ribose-5-phosphate, supporting antioxidant defense and nucleotide synthesis, respectively. Glyceraldehyde-3-phosphate and downstream intermediates supply carbon for glycerol backbones and for the synthesis of selected nonessential amino acids. Glycolysis thus acts as a “distribution center” coordinating energy metabolism and biosynthesis.
(2) The significance of the three-carbon intermediate pool in carbon allocation
Three-carbon intermediates such as dihydroxyacetone phosphate (DHAP) lie midstream in glycolysis and represent a key node linking glucose catabolism to lipid synthesis. DHAP can be converted to glycerol-3-phosphate, providing the backbone for triglyceride and phospholipid synthesis. The size and dynamics of this three-carbon pool reflect carbon-flow coupling between glycolysis and lipid biosynthesis and are informative for understanding metabolic reprogramming.
III. Pyruvate branching and lactate production: cytosolic redox balance
3.1 Diversion of pyruvate to lactate and its functional role
(1) LDH catalysis and the mechanism of NAD⁺ regeneration
Under LDH catalysis, pyruvate is reduced to lactate while NADH is oxidized to NAD⁺. Although this reaction does not generate additional ATP, it is essential for sustaining upstream glycolytic steps because insufficient NAD⁺ regeneration constrains reactions such as glyceraldehyde-3-phosphate dehydrogenase, thereby reducing glycolytic flux. Accordingly, lactate production can be viewed as an “electron release” route when oxygen supply is insufficient or mitochondrial oxidation is constrained.
(2) Lactate export and microenvironmental modulation
Lactate is exported via monocarboxylate transporters together with H⁺, contributing to local acidification. An acidic microenvironment can affect extracellular matrix remodeling, enzyme activities, and immune-cell functions. In tumors, lactate accumulation is closely associated with immunosuppression and increased invasiveness; in normal tissues with high metabolic loads, lactate can be re-uptaken and oxidized by neighboring or distal cells, forming inter-tissue metabolic coupling.
(3) Related products (Aladdin)
Analyte/Readout | Catalog No. | Product Name | Grade and Purity | Application |
L-lactate content (core readout of lactate generation/branching) | L-Lactic acid (L-LA) Content Assay Kit (WST-8, Micro Method) | BioReagent | Quantifies L-lactate to assess diversion of pyruvate to lactate and enhanced lactate production/export; recommended to interpret alongside pyruvate, glucose consumption, and ATP to improve discrimination of “enhanced glycolysis/limited mitochondrial oxidation” | |
Pyruvate content (glycolytic endpoint/TCA-entry branching readout) | Pyruvic Acid (PA) Content Assay Kit (DNPH, Micro Method) | BioReagent | Quantifies pyruvate to evaluate terminal glycolytic production and diversion toward mitochondrial oxidation; combined with lactate and ATP to distinguish lactate-fermentation bias from aerobic-oxidation bias | |
Cytotoxicity/membrane integrity (LDH-release QC) | Lactate Dehydrogenase (LDH) Cytotoxicity Assay Kit (WST-8, Micro Method) | BioReagent | Assesses cell damage/cytotoxicity to differentiate true metabolic-flux changes from artifacts due to cell death or membrane rupture; recommended as a concurrent QC alongside lactate/pyruvate assays |
3.2 Diversion of pyruvate to mitochondria and metabolic consequences
(1) Pyruvate transport and the PDH complex
Pyruvate enters the mitochondrial matrix via specific transporters and is oxidatively decarboxylated by the pyruvate dehydrogenase (PDH) complex to generate acetyl-CoA. This step produces NADH and releases CO₂, serving as the key bridge between glycolysis and the TCA cycle. PDH activity is regulated by phosphorylation status, substrate/product levels, and multiple metabolic signals; PDH downregulation promotes pyruvate accumulation and shifts flux toward lactate.
(2) Branching of pyruvate and its relationship to energy efficiency
Under aerobic conditions, routing pyruvate into the TCA cycle yields substantially more ATP than glycolysis alone. Therefore, changes in the fraction of pyruvate allocated to mitochondria directly influence the energy yield per unit glucose. In highly proliferative states, cells often partially restrict pyruvate entry into the TCA cycle, retaining more carbon within glycolysis and associated shunts for biosynthesis, while using substrates such as glutamine to replenish TCA intermediates and maintain an overall balance between energy production and anabolism.
IV. The TCA cycle and energy output: biochemical bases of citrate, DHAP, and ATP
4.1 Structure and function of the TCA cycle
(1) Entry of acetyl-CoA into the TCA cycle
Acetyl-CoA condenses with oxaloacetate under citrate synthase (CS) catalysis to form citrate, marking the entry into the TCA cycle. Citrate undergoes successive rearrangement and oxidative decarboxylation steps to generate isocitrate, α-ketoglutarate, succinyl-CoA, malate, and other intermediates, ultimately regenerating oxaloacetate. Each turn produces multiple NADH molecules and one FADH₂, supplying electron donors to the respiratory chain.
(2) Coupling of the TCA cycle to oxidative phosphorylation
Within the mitochondrial inner membrane, the electron transport chain transfers electrons from NADH and FADH₂ to oxygen, driving proton pumping to establish a proton electrochemical gradient. ATP synthase uses this gradient to synthesize ATP. TCA flux is tightly coupled to electron transport capacity, oxygen availability, and ADP levels, together determining aerobic ATP-generating capacity. Changes in key intermediates (e.g., succinate and fumarate) can be quantified as readouts of TCA turnover.
(3) Related products (Aladdin)
Analyte/Readout | Catalog No. | Product Name | Grade and Purity | Application |
Succinate content (mid-cycle TCA intermediate) | Succinate Assay Kit | 200 assays (microplate) | Quantifies succinate to assess mid-cycle carbon flow and intermediate accumulation/consumption; can be integrated with fumarate, citrate, and ATP to evaluate changes in mitochondrial oxidative capacity | |
Fumarate content (mid-to-late cycle TCA intermediate) | Fumarate Assay Kit | 96 tests | Quantifies fumarate to reflect late-cycle turnover and anaplerotic relationships; paired succinate–fumarate measurements can help localize bottlenecks within the TCA pathway |
4.2 Connections between TCA intermediates and upstream pathways
(1) Citrate as a hub linking the TCA cycle and lipid biosynthesis
Beyond cycling within the TCA pathway, citrate can be exported to the cytosol via the citrate–malate shuttle and cleaved by ATP citrate lyase to yield acetyl-CoA and oxaloacetate, supplying acetyl-CoA for fatty-acid and cholesterol biosynthesis. Citrate levels therefore reflect both TCA entry flux and carbon withdrawal toward lipid synthesis. Elevated citrate can also feedback-inhibit PFK, serving as an important cross-pathway regulatory signal.
(2) DHAP as a coupling node between mid-glycolysis and lipid synthesis
DHAP can be converted to glycerol-3-phosphate by glycerol-3-phosphate dehydrogenase; glycerol-3-phosphate provides the backbone precursor for triglycerides and many glycerophospholipids. DHAP therefore reports not only the status of mid-glycolytic intermediate pools but also the carbon supply capacity toward lipid biosynthesis. High-sensitivity DHAP measurement can help resolve fine regulation between glucose catabolism and lipid synthesis during metabolic reprogramming.
4.3 ATP levels and cellular energy homeostasis
(1) Dynamic balance between ATP production and consumption
ATP is maintained through continuous synthesis and hydrolysis. Under aerobic conditions, the TCA cycle and oxidative phosphorylation are the primary ATP sources, whereas glycolysis can rapidly supply ATP under hypoxia or acute high-demand scenarios. Ongoing ATP consumption arises from ion pumping, anabolic metabolism, and contractile/motile processes. Cells sense ATP/ADP/AMP ratios and regulate metabolism through energy-sensing pathways such as AMPK to maintain energy homeostasis.
(2) Biological interpretation of ATP readouts
ATP measurements provide an integrated snapshot of overall cellular energy status at a given time point. Stable or mildly increased ATP can indicate enhanced metabolism with adequate compensation, whereas marked decreases suggest constraints in ATP production, excessive energy load, or globally reduced cell viability. Interpreting ATP together with glucose uptake/consumption, lactate and pyruvate production, citrate and DHAP levels, and key enzyme activities enables discrimination between pathway-specific regulation and nonspecific cytotoxicity.
(3) Related products (Aladdin)
Analyte/Readout | Catalog No. | Product Name | Grade and Purity | Application |
ATP content (core readout of cellular energy status) | ATP Determination Kit | BioReagent, ready-to-use, for chemiluminescence | Quantifies ATP by chemiluminescence to report overall energy status in cells/tissues; suitable for rapid readout and parallel multi-sample testing; can be integrated with glucose, lactate/pyruvate, and TCA-intermediate measurements to distinguish limited ATP production from altered substrate supply | |
ATP content (core readout of cellular energy status) | Enhanced ATP Assay Kit | BioReagent | Quantifies ATP to assess energy-output capacity; recommended to interpret with glucose consumption, lactate/pyruvate, and TCA intermediates to separate production constraints from substrate-driven changes | |
Ca²⁺/Mg²⁺-ATPase activity (energy-consumption and membrane-transport load) | Ca²⁺/Mg²⁺-ATPase Activity Assay Kit (AHM, Micro Method) | BioReagent | Measures Ca²⁺/Mg²⁺-dependent ATPase activity as an indicator of ATP consumption and ion-homeostasis maintenance load; supports interpretation of whether ATP decreases arise from impaired production or increased consumption | |
Na⁺/K⁺-ATPase activity (representative basal energy expenditure) | Na⁺/K⁺-ATPase Activity Assay Kit (AHM, Micro Method) | BioReagent | Measures Na⁺/K⁺ pump–associated ATPase activity to evaluate basal energy expenditure and membrane electrochemical-gradient maintenance; combining with ATP content and mitochondrial function readouts improves interpretation of energy-homeostasis changes |
V. Key enzyme activities and mechanistic identification of metabolic bottlenecks
5.1 Functional significance of glycolytic gatekeeping enzymes
(1) PFK activity and regulation of glycolytic throughput
As the major rate-limiting enzyme of glycolysis, PFK is finely regulated by multiple metabolic signals. High ATP levels inhibit PFK allosterically, whereas AMP and fructose-2,6-bisphosphate strongly activate it. Citrate and proton concentration (H⁺) also modulate PFK, rendering glycolysis highly responsive to energy status and acid–base conditions. Measuring PFK activity helps determine whether enhanced or reduced glycolytic flux is directly driven by regulation at this canonical bottleneck.
(2) HK activity and glucose utilization efficiency
HK catalyzes the formation of glucose-6-phosphate and represents the initiating step committing glucose to the metabolic network. HK interactions with the mitochondrial outer membrane can enhance local ATP availability, thereby improving phosphorylation efficiency. In many tumor contexts, HK2 is upregulated and associates with mitochondria, strengthening glucose utilization. HK activity thus reflects the “capture efficiency” of glucose substrate and, when combined with glucose uptake/content assays, supports differentiation between regulation at transport versus initial phosphorylation.
5.2 Mitochondrial entry of pyruvate and regulation at the TCA gateway
(1) PDH activity and pyruvate oxidative capacity
The PDH complex converts pyruvate to acetyl-CoA and is a critical gatekeeper between glycolysis and the TCA cycle. PDH is inhibited by phosphorylation via PDH kinase (PDK) and activated by dephosphorylation via PDH phosphatase. Hypoxia, certain hormones, and metabolic cues can upregulate PDK to suppress PDH, diverting pyruvate toward lactate and promoting Warburg-like metabolism. PDH activity assays can directly establish whether entry of pyruvate into the TCA cycle is restricted.
(2) CS and α-KGDH as indicators of TCA pathway status
CS catalyzes the condensation of acetyl-CoA and oxaloacetate and serves as both an entry enzyme for the TCA cycle and a commonly used indicator of mitochondrial content and baseline TCA capacity. α-Ketoglutarate dehydrogenase (α-KGDH) resides mid-cycle and is a major NADH-producing step; its activity can significantly influence overall cycle throughput and reactive oxygen species generation. Changes in CS and α-KGDH activities can therefore characterize TCA capacity and help locate key bottlenecks.
Cellular energy metabolism is a core network integrating energy supply, biomass synthesis, and cell-fate decision-making. A measurement framework built around glycolysis, pyruvate branching, and the TCA cycle—through integrated assessment of glucose, lactate, pyruvate, citrate, DHAP, ATP, and key enzyme activities—enables biochemical profiling of metabolic states and reprogramming signatures across cell types and perturbations. With appropriate experimental design and rigorous interpretation, these readouts provide not only descriptive metabolic phenotypes but also mechanistically informative evidence, supporting metabolism-focused studies in basic research and drug discovery.
Aladdin: https://www.aladdinsci.com/